396 related articles for article (PubMed ID: 35321516)
41. Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer.
Ma XB; Xu YY; Zhu MX; Wang L
Front Oncol; 2020; 10():591739. PubMed ID: 33680920
[TBL] [Abstract][Full Text] [Related]
42. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
43. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
[TBL] [Abstract][Full Text] [Related]
44. Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients.
Liu J; Huang X; Liu H; Wei C; Ru H; Qin H; Lai H; Meng Y; Wu G; Xie W; Mo X; Johnson CH; Zhang Y; Tang W
J Transl Med; 2021 Jan; 19(1):27. PubMed ID: 33413474
[TBL] [Abstract][Full Text] [Related]
45. Identification of glutamine metabolism-related gene signature to predict colorectal cancer prognosis.
Xie Y; Li J; Tao Q; Wu Y; Liu Z; Zeng C; Chen Y
J Cancer; 2024; 15(10):3199-3214. PubMed ID: 38706895
[No Abstract] [Full Text] [Related]
46. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
Li F; Zhang Y; Shi Y; Liu S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
[TBL] [Abstract][Full Text] [Related]
47. Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer.
Song J; Wu L
Front Mol Biosci; 2020; 7():148. PubMed ID: 32793631
[TBL] [Abstract][Full Text] [Related]
48. TNFRSF11B Suppresses Memory CD4+ T Cell Infiltration in the Colon Cancer Microenvironment: A Multiomics Integrative Analysis.
Zhang JR; Hou P; Wang XJ; Weng ZQ; Shang-Guan XC; Wang H; You F; Lin BQ; Huang ZY; Chen XQ
Front Immunol; 2021; 12():742358. PubMed ID: 34938284
[TBL] [Abstract][Full Text] [Related]
49. Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer.
He Y; Wu Y; Liu Z; Li B; Jiang N; Xu P; Xu A
Front Genet; 2021; 12():694777. PubMed ID: 34589112
[No Abstract] [Full Text] [Related]
50. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
51. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
[TBL] [Abstract][Full Text] [Related]
52. Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer.
Shen Y; Guan Y; Hummel JJ; Shyu CR; Mitchem JB
BMC Cancer; 2020 Feb; 20(1):124. PubMed ID: 32059711
[TBL] [Abstract][Full Text] [Related]
53. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
[No Abstract] [Full Text] [Related]
54. Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li J; Xiao Y
Biomed Res Int; 2020; 2020():8896511. PubMed ID: 33195699
[TBL] [Abstract][Full Text] [Related]
55. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
56. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
[TBL] [Abstract][Full Text] [Related]
57. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic cancer.
Zou W; Li L; Wang Z; Jiang N; Wang F; Hu M; Liu R
Bioengineered; 2021 Dec; 12(1):9006-9020. PubMed ID: 34654352
[TBL] [Abstract][Full Text] [Related]
58. Identification of macrophage-related molecular subgroups and risk signature in colorectal cancer based on a bioinformatics analysis.
Liu Q; Liao L
Autoimmunity; 2024 Dec; 57(1):2321908. PubMed ID: 38466182
[TBL] [Abstract][Full Text] [Related]
59. A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma.
Yang C; Huang S; Cao F; Zheng Y
BMC Cancer; 2021 Nov; 21(1):1182. PubMed ID: 34740325
[TBL] [Abstract][Full Text] [Related]
60. Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma.
Sun Q; Li Y; Yang X; Wu X; Liu Z; Mou Y; Song X
Front Immunol; 2021; 12():782216. PubMed ID: 34880875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
